Evolution of the Average Target: Revvity, Inc.

Evolution of the Target Price: Revvity, Inc.

Changes in Analyst Recommendations: Revvity, Inc.

61.gU4kES4ogDapbVlmwWMNF6x0sGyRjtRMThCTIkG4qo8.zREXKWdEzgHKNW8Hu1tnXe83-iH1xOx-FnfUERDNmdjPD0JVHGnNVZsoaQ~dfa21cb6a5b590f6c6415d5cae5e338e
05-04 Baird Adjusts Revvity Price Target to $125 From $129, Maintains Outperform Rating MT
04-14 Barclays Downgrades Revvity to Equalweight From Overweight, Adjusts Price Target to $95 From $118 MT
04-13 Goldman Sachs Adjusts Price Target on Revvity to $95 From $110, Maintains Neutral Rating MT
04-13 TD Cowen Adjusts Price Target on Revvity to $115 From $124, Maintains Buy Rating MT
04-06 Evercore ISI Adjusts Revvity Price Target to $108 From $118, Maintains Outperform Rating MT
03-31 JPMorgan Adjusts Price Target on Revvity to $96 From $105, Maintains Neutral Rating MT
02-03 Wells Fargo Adjusts Price Target on Revvity to $110 From $107 MT
02-03 TD Cowen Adjusts Revvity PT to $124 From $120 MT
02-03 Baird Adjusts Price Target on Revvity to $129 From $123 MT
02-03 Raymond James Adjusts Price Target on Revvity to $132 From $115 MT
02-03 JPMorgan Adjusts Price Target on Revvity to $105 From $100 MT
02-03 Jefferies Adjusts Price Target on Revvity to $105 From $100 MT
02-03 Evercore ISI Adjusts Price Target on Revvity to $118 From $112 MT
02-03 Barclays Adjusts Price Target on Revvity to $118 From $115 MT
02-02 Evercore ISI Raises Revvity Price Target to $118 From $112 MT
01-20 Goldman Sachs Raises Price Target on Revvity to $110 From $105, Maintains Neutral Rating MT
01-16 Leerink Partners Adjusts Price Target on Revvity to $140 From $120, Maintains Outperform Rating MT
12-15 Revvity Shares Fall After BofA Downgrade MT
12-15 Barclays Adjusts Price Target on Revvity to $115 From $105, Maintains Overweight Rating MT
12-15 Wells Fargo Adjusts Price Target on Revvity to $107 From $102, Maintains Equalweight Rating MT
12-15 BofA Securities Downgrades Revvity to Neutral From Buy MT
25-10-28 Baird Adjusts Price Target on Revvity to $123 From $122, Maintains Outperform Rating MT
25-10-28 Barclays Adjusts Price Target on Revvity to $105 From $100, Maintains Overweight Rating MT
25-10-27 Evercore ISI Adjusts Revvity Price Target to $108 From $106 MT
25-10-27 (RVTY) Revvity Expects 2025 Adjusted EPS Range $4.90 to $5.00, vs. FactSet Est of $4.86 MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+16.18%
+29.78%
+40.5%
+36.33%
+71.52%
+11.82%
+40.91%
+28.97%
+12.12%
+30.37%
Average +31.85%
Weighted average by Cap. +35.36%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
100.00USD
Average target price
113.64USD
Spread / Average Target
+13.64%
High Price Target
145.00USD
Spread / Highest target
+45.00%
Low Price Target
90.00USD
Spread / Lowest Target
-10.00%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Baird
Barclays
Goldman Sachs
TD Cowen
Evercore ISI
JPMorgan Chase
Wells Fargo Securities
Raymond James
Jefferies & Co.
Leerink Partners
BofA Securities
Guggenheim
Bernstein
Stifel Nicolaus
UBS
KeyBanc Capital Markets
Citigroup
Nephron Research
Cowen
Credit Suisse
BMO Capital
Wolfe Research
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
100.00USD
Average target price
113.64USD
Spread / Average Target
+13.64%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RVTY Stock
  4. Consensus Revvity, Inc.
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!